Home / Therapies / Sulfonylurea (page 9)


ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #17: Insulin, Part 2 of 3


Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor PEDIATRICS – Jane Lee Chiang, MD, and Georgeanna J. Klingensmith, MD ADULTS – Irl B. Hirsch, MD 1. Basal insulin accounts for ~50% of total daily dose: i. LAA (insulin glargine, detemir, degludec) or NPH if LAA …

Read More »

Avandia, Not Coumadin — Coumadin, Not Avandia


From our partners at ISMP (Institute for Safe Medication Practices) – Last week the US Food and Drug Administration (FDA) notified health professionals about their determination that recent data for rosiglitazone-containing drugs, such as Avandia, combination products (Avandaryl [rosiglitazone and glimepiride] and Avandamet [rosiglitazone and metformin]), and generics, do not show an increased …

Read More »